An interview with Philip Biggin, Section Editor for Computational, in silico and modelling studies.

Journal article

Abstract:: Phil Biggin, PhD, is a group leader in the Department of Biochemistry, University of Oxford. He is interested in computational approaches to receptor dynamics and ligand-binding. His group uses a wide range of methodologies ranging from molecular dynamics simulations through to machine learning techniques to address fundamental problems in pharmacology. He is the Section Editor for Computational, in silico and modelling studies for BMC Pharmacology and Toxicology. In this interview we find out a little more about the key issues in this field of research.

Files:: 2050-6511-13-2.pdf

(Preview, Version of record, pdf, 150.5KB, Terms of use)

Language:: English
Keywords:: Computer Simulation

Pharmacology

Models, Biological

Computational Biology
Pubs id:: pubs:350520
UUID:: uuid:efdda172-2213-41e3-92c9-e69f281b2a3a
Local pid:: pubs:350520
Source identifiers:: 350520
Deposit date:: 2013-11-17
ARK identifier:: ark:/29072/ora_efdda172221341e392c9e69f281b2a3a

Copyright holder:: Philip C Biggin
Notes:: © 2012 Biggin; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

If you are the owner of this record, you can report an update to it here: Report update to this record